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Abstract
Introduction Traumatic spinal cord injury (SCI) triggers complex changes that can negatively impact health and quality of
life. The International SCI Data Sets were developed to enable more comparable data collection on the complex sequelae of
SCI across studies. This should facilitate progress in mechanistic understanding and improving treatments of SCI.
Study design Prospective observational pilot study.
Objectives To collect data on pain symptoms and quality of life (QoL) in adults living with chronic SCI.
Setting Academic medical center, New York, USA.
Methods The International SCI Basic Pain and Qol Data Sets were used to collect data from participants with chronic SCI
(N = 31) at 2 study visits held 6 months apart. The QoL Data Set was also used to collect data from able-bodied persons of
similar age and gender distribution (N = 28).
Results Most participants with SCI had multiple types and locations of pain problems at both study visits, despite reported
being treated for pain. At both visits, the worst pain problem type was nociceptive, followed by neuropathic, which was
typically rated of higher intensity. QoL scores were signiﬁcantly lower across all domains of the data set in persons with SCI
than able-bodied persons. Persons with pain tended to have lower QoL scores, although this trend was not signiﬁcant.
Conclusions This study demonstrates the presence, complexity and stability of pain symptoms refractory to treatment and
lower quality of life ratings in persons with chronic SCI.
Sponsorship Grants from the Craig H. Neilsen Foundation, New York Empire Clinical Research Program, New York State
Spinal Cord Injury Research Board.

Introduction
Pain is recognized as a most common medical consequence
of traumatic spinal cord injury (SCI), with prevalence rates
estimated to be ~60% [1, 2]. For many individuals with
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SCI, pain severity remains consistent over time. In data
from the NIH SCI Model Systems database, on a scale of
0–10, where 0 is none and 10 is the worst pain, the mean
score for pain severity after injury was 4.2 at year 1, 4.5 at
year 10, 4.3 at year 20, and 4.2 at year 40 [3]. Pain interferes
with quality of life (QoL); in the Model Systems database,
at 1 year after injury, interference of pain with work was:
“not at all” for 18%, “a little bit” for 21%, “moderately” for
14%, “quite a bit” for 12.8%, and “extremely” for 6.4% of
respondents [3]. Data from the Model Systems also show
that pain interference increased with time: no pain interference was lowest at 1 year and highest at 25 years after
SCI [3].
With high prevalence, complexity, and persistence of
pain in persons with SCI, Bryce, Ragnarsson and colleagues
have had a longstanding effort to develop a reliable pain
taxonomy to facilitate better mechanistic understanding and
treatment [4–6]. Recently, common data elements were
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created to facilitate characterization of pain and other
complex medical and psychosocial sequalae of SCI [7, 8].
The International SCI Pain Basic Data Set (ISCIPBDS)
standardizes the characterization and reporting of SCI pain
across studies [9]. It builds on the International SCI Pain
Classiﬁcation (ISCIP) to classify pain ﬁrst by type (nociceptive, neuropathic, other, or unknown), subtype (nociceptive: musculoskeletal, visceral, or other, neuropathic: at
or below level, or other unrelated to the injury) and then by
pain source and/or pathology [10]. In accordance with
ISCIP, ISCIPBDS includes questions about a person’s 3
worst pain problems, including: pain types and subtypes,
locations, intensities, frequency, and duration, as well as
some basic information on how pain interferes with activities of daily living, mood, sleep and social participation [9].
The ISCIPBDS was recently found to have good validity as
a self-reported measure of pain [11]. A second version of
the ISCIPBDS was simpliﬁed to facilitate use, eliminating
some questions about pain chronicity, some pain interference questions and adding a category of “other” to pain
type [12]. The ISCIPBDS also contains a few questions on
pain interference to relate how pain impacts QoL. Satisfaction with QoL is also addressed in an independent
International SCI QoL Basic Data Set, which has been
shown to have good validity in the SCI population [13, 14].
Here, the main objective was to characterize symptoms
of pain using the ISCIPBDS in adults with chronic SCI (≥1
year from initial injury). To characterize pain persistence
and variability in the chronic phase of SCI, data were
obtained at 2 study visits held 6 months apart. A secondary
goal was to collect data using the International SCI QoL
Basic Data set to examine potential inverse correlations
between pain symptoms and satisfaction with QoL.

Methods
This prospective, observational study was performed in an
academic medical center in accordance with ethical standards and with approval from the local IRB. Inclusion criteria were: ≥18 years old, history of SCI at any level,
traumatic SCI at least 1 year prior, American Spinal Injury
Association Impairment Scale (AIS) grades A–D, as
determined by a physiatrist board certiﬁed in SCI medicine.
Exclusion criteria were: concurrent infection such as frank
urinary tract infection as indicated by lab evidence (urinalysis, positive culture) and some clinical occurrence such as
hematuria, fever; incontinence between catheterizations;
pressure ulcers, cancer, chemotherapy, neutropenia, or
autoimmune disease. Many, but not all, study participants
received medical care at the study institution, so some
relevant information, including medication lists, were more
complete for some participants than for others. For example,
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although opioids are not currently recommended for pain
treatment in persons with SCI and are not commonly prescribed at the study institution, some participants reported
prescriptions for opioids when asked if they were taking
medications for pain. Functional genomic and biochemical
data from some of the same participants were published
previously [15, 16]. A group of similar age able-bodied
individuals (N = 28) were recruited for comparison.
To address persistence and variability of pain symptoms in
chronic SCI, participants with SCI were asked to complete
two study visits held six months apart. Most participants
(81%) completed both visits. Pain data were collected using
ISCIPBDS (v1.1 & 2.0). Since the numerical rating scale of
pain intensity changed between versions, data were normalized as a percentage of the scale (1–10) used in version 2.
Additional data (e.g., medications potentially related to pain
management) was requested by interview from participants or
abstracted from participants’ medical charts when available.
QoL data were collected using the International SCI Quality
of Life Basic Data set. Descriptive statistics (frequency distribution for categorical variables and mean, median, SD,
minimum, and maximum for continuous variables) were
calculated. Chi square and Fisher’s Exact tests were performed to test associations between pain, injury status, and
mechanism of injury. Mann–Whitney Rank Sum test was
performed to test if there was any difference in years after
injury in persons with or without pain, and difference in
average pain intensity and in QoL scales among participants
with different SCI levels, neurological injury motor status, or
mechanisms of injury. As this was an exploratory study, no
corrections were made on multiple tests. However, the Dwass,
Steel, Critchlow-Fligner (DSCF) correction for multiple levels
comparison analysis was applied to the Rank Sum test if the
overall analysis was signiﬁcant. Box plots were used to
visualize average differences between groups in
Mann–Whitney Rank Sum test. Spearman correlations were
calculated to examine associations of years after injury and
QoL scales, and of average pain intensity and QoL scales.
Potential differences in pain symptoms between study visits
and potential correlations between pain symptoms and QoL
were examined among SCI participants, where data were
available. For comparison, QoL data were also collected from
a group of able-bodied persons (N = 28). Statistical analyses
were performed using SAS v9.3 (SAS Inc., Cary, NC) and
Prism GraphPad 6 Software.

Results
Participant characteristics
Basic clinical and demographic information for participants
is shown in Table 1. Participants (81% males) were
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Table 1 Participant demographics
Mean ± SEM, Range
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Table 2 Treatments related to pain management. Data were collected
by interview with participants and supplemented, when available, by
examination of their medical charts

Age: years

Participants (%)

Able-bodied (AB) persons (N = 28)

48 ± 2, 23–66

Persons with chronic SCI (N = 31)

55 ± 3, 21–80

Gender: male

N

AB

22

SCI

22

Years post injury
Mechanism of injury

15.7±2, 1–44
N

Fall

10

MVA

7

Sports

10

Other

4

AIS grade

N

A

16

B

2

C

4

D

9

Level of injury

N

Cervical

18

Thoracic

11

Lumbar

2

individuals living with SCI for ≥1 year and had an average
time from injury of 15.7 ± 2.3 years (mean ± SEM). The
average age of participants with SCI was 55.0 ± 3 (mean ±
SEM), and range was 21–80 years. The mechanisms of
injury were: Fall (32%), Sports (32%), MVA (23%), and
Other (13%). Most participants had cervical level injuries
(58%), followed by thoracic (36%) and lumbar (6%).

International SCI pain data set
The ISCIPBDS asks if respondents are receiving any
treatments for any type of pain (neuropathic, nociceptive, or
other) problems. Therefore, participants were asked by a
study investigator if they were using any kind of pain
management strategy. (Some study participants received
medical care from the study institution and therefore more
complete medication records were available for some participants.) A majority of participants (76% and 68% at visits
1 and 2, respectively) reported using multiple concurrent
medications or therapeutic strategies that may have been
related to pain management (Table 2). Pharmacological
treatments that participants reported may have been related
to pain management most commonly included pregabalin or
gabapentin, followed by NSAIDS with or without aspirin,
and others (Table 2). Other strategies were also reported
(Table 2).

A. Pharmacological
Anti-epileptics (pregabalin, gabapentin)

32

NSAIDS with Aspirin

32

NSAIDS without Aspirin

19

Opioids (morphine, oxycodone, buprenorphine)

26

Benzodiazepines

10

Anti-depressants

6.5

Muscle relaxers

3

Epidural steroid injection

3

B. Non-pharmacological
Physical therapy

13

Massage

3

Heat

3

Magnet therapy

3

Total percent exceeds 100%, due to participants using more than one
therapeutic strategy

At each study visit, a member of the study team asked
participants about their pain symptoms as speciﬁed by the
ISCIPBDS. The ﬁrst question asked is if the participant has
had any pain during the last seven days including today.
Among participants, 67% and 76% had pain at visit 1 and 2,
respectively (Fig. 1a). Most participants had more than one
pain problem at each study visit (Fig. 1b). Among participants with pain, 47% had neuropathic and 53% had nociceptive types of pain problems. The next question asked is
if the participant can rank the type of their three worst pain
problems. At both study visits, the worst type of pain problem reported was nociceptive (53%) (Table 3a). At both
visits 1 and 2, within the worst pain problem, the most
common subtype of nociceptive pain was musculoskeletal
(Table 3a). Neuropathic pain was characterized most commonly as below level (Table 3a). Data on location, type,
intensity, and frequency of pain was then collected for the
second and worst pain problems (Table 3a).
The pain intensity by pain type was reported according to
a numerical rating scale of 0–10, where 0 is “no pain” and
10 is “pain as bad as you can imagine”. At visit 1, for the
worst pain problem, the average pain intensity scores ranged from 1–10. Although more participants reported nociceptive as their worst type of pain problem, the average pain
intensity scores were higher for the fewer participants, who
reported neuropathic as their worst type of pain problem
(Fig. 2). In version 1 of the ISCIPBDS, it then asked about
duration and frequency of pain. This data were not collected
consistently from participants here and is therefore not
reported; this data collection was removed from ISCIPBDS
version 2.
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Fig. 1 Pain Status and Number
of Pain Problems: a x-axis
shows the number of
participants who reported pain
(yes/no, y-axis). b x-axis shows
the number of pain problems
that were reported (0–4 or at
least 5) by the number of
participants indicated on the yaxis. Data are shown for visit 1
(black), visit 2 (gray)

Table 3 Ranking and location of three worst reported pain problems.
Data were collected by interview with participants on the three worst
pain problems they experienced within the last seven days, by pain
type and location
Pain problem by rank

1st
Visit

1

2nd
2

1

3rd
2

1 2

A. Pain types
Pain type
Nociceptive

Neuropathic

Musculoskeletal 10 9

8

4

4 4

Visceral

0

0

0

0 2

Subtotal

10 10 8

4

4 6

Below

5

3

2 0

5

1

At

3

3

0

1

0 1

Other

0

0

1

0

0 0

Subtotal

8

8

2

4

2 1

1

0

3

2

1 0

Unknown
All types

1

Total

19 18 13 10 7 7

B. Pain locations
Pain location
Head

0

0

0

0

1 1

Neck/shoulders

6

5

3

2

2 3

Arm/hands

1

1

3

2

1 0

Frontal torso/genitals

4

3

2

1

1 1

Back

5

3

3

3

3 1

Buttocks/hips

1

1

0

1

0 0

Upper legs/thighs

3

4

2

1

0 1

Lower legs/feet

1

2

1

1

1 0

All locations

Total

21 19 14 11 9 7

The ISCIPBDS asks respondents to identify their pain
locations/sites for each of their three worst pain problems.
The pre-speciﬁed location choices are shown in Table 3.
Neck/shoulders was the most common location for the
worst pain problem at visit 1 or 2 (Table 3b). This was
followed by back, frontal torso/genitals and then upper legs/
thighs (Table 3b). The location of the 2nd worst pain problem was more evenly reported at neck/shoulders, arm/

hands, and back (Table 3b), while the most common location of the third worst pain problem was back (visit 1) and
neck/shoulders (Table 3b).
ISCIPBDS (version 1) included six questions to characterize aspects of pain interference with activities of living,
using a 0–10 scale, where 0 is no interference and 10 is
extreme interference. Questions in version 1 asked about
effects of pain during the past week: (1) how did pain limit
activities, (2) how did pain change the ability to participate
in recreational and social activities, (3) how much did pain
change satisfaction or enjoyment in family activities, (4)
how did pain interfere with daily activities in general, (5)
how did pain interfere with overall mood in general, and (6)
how did pain interfere with the ability to sleep at night?
Version 2 retained only the latter three questions on daily
activity, mood, and sleep. Answers were recorded for most
participants at both study visits, (N = 21/31 participants at
visit 1 and N = ≥18/25 participants at visit 2). In response to
the question: “In general, how much has pain interfered
with your day-to-day activities in the last week?,” 39% and
22% of participants with recorded responses at visits 1 and
2 said there was no interference (Fig. 3a). In response to the
question: “In general, how much has pain interfered with
your overall mood in the past week?,” 43% and 22% of
participants with recorded responses at visits 1 and 2 said
there was no interference (Fig. 3b). In response to the
question: “In general, how much has pain interfered with
your ability to get a good night’s sleep?”, 24% and 20% of
participants with recorded responses at visits 1 and 2 said
there was no interference (Fig. 3c).
Although this was a pilot study with a small number of
participants, we next examined if the presence, type,
intensity, or location of pain correlated with any clinical or
demographic variables. Forty percent of participants without pain had complete neurological injury motor status,
while 57% among participants with pain. The frequency
distribution of mechanism of injury was: Fall (40%), MVA
(20%), Sports (40%) for participants without pain, and Fall
(29%), MVA (24%), Sports (29%), and others (19%) in the
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Fig. 2 Pain intensity for the
worst reported pain problem: the
intensity of the worst reported
pain problem (either nociceptive
or neuropathic) by type for Visit
1 (a) and Visit 2 (b)

group with pain. The age of participants without pain was
54 ± 16.9 and 55 ± 14.9 (mean ± SEM) in participants with
pain. The number of years after injury was 13 ± 12.4 in
participants without pain and 17 ± 13.0 (mean ± SEM) in
participants with pain. Participants with pain reported an
average of 6 ± 2.4 (mean ± SEM) numerical rating scale
(NRS) units of pain intensity. Pain presence did not show a
signiﬁcant association with SCI level, neurological injury
motor status, or mechanism of injury. There was no difference in the years after injury between participants with or
without pain (p = 0.503). Average pain intensity was not
different between SCI levels (p = 0.65), neurological injury
motor status (p = 0.817), or by mechanisms of injury (p =
0.281). There was a negative Spearman correlation coefﬁcient between average pain intensity and years after injury,
but this was not statistically signiﬁcant (p = 0.2065). Participants with neuropathic pain showed a negative and
signiﬁcant correlation (ρ = −0.84979, p = 0.004) between
years post-injury and the average pain intensity. Stratifying
participants by SCI level, neurological injury motor status,
or mechanism of injury also did not show signiﬁcant correlation among year of post-injury and pain intensity.

International SCI quality of life data set
Many tools have been used to measure QoL in persons with
SCI [17]. The International SCI QoL Basic Data Set asks
participants to provide a subjective rating of the past four
weeks in three domains: general QoL (overall well-being),
satisfaction with physical health, and satisfaction with
psychological health. Each domain is ranked on a
0–10 scale, with 0 indicating completely dissatisﬁed and 10
indicating completely satisﬁed. Here, we used the International SCI QoL Basic Data Set as compared to a group of
similar age able-bodied (AB) persons (N = 28). The general
QoL score was signiﬁcantly lower in persons with SCI vs.
AB controls (7.2 ± 0.4 vs. 8.5 ± 0.25 mean ± SEM, p <
0.007). The satisfaction with physical health score was
signiﬁcantly lower in persons with SCI vs. AB controls
(6.3 ± 0.5 vs. 8.1 ± 0.24 mean ± SEM, p < 0.005). The

satisfaction with psychological health score was signiﬁcantly lower in persons with SCI vs. AB controls (7.4 ±
0.4 vs. 8.7 ± 0.2 mean ± SEM, p < 0.02). This study shows
that QoL was signiﬁcantly lower across all domains of the
International SCI QoL Basic Data Set.
Of course, QoL in persons with SCI can be inﬂuenced by
multiple factors including comorbidities, socioeconomic
status, psychosocial support, access to health services, and
others. Given that we used both the pain and QoL data sets
in the same participants, we next investigated whether QoL
scores differed in participants with SCI by pain status.
While lower, there was not a signiﬁcant correlation between
pain status and QoL scores: QoL rating of physical health,
and satisfaction with psychological health were 8 ± 1.3, 7 ±
2.1, and 8 ± 1.2 in the group without pain and 7 ± 2.6, 6 ±
2.7, and 7 ± 2.6 in the group with pain. The average pain
intensity had a negative, but not signiﬁcant, correlation with
general QoL (ρ = −0.102. p = 0.668, N = 20), rating of
physical health (ρ = −0.392. p = 0.088, N = 20), and
satisfaction with psychological health (ρ = −0.177. p =
0.454, N = 20). Participants with pain showed a signiﬁcant
difference in the rating of physical health by neurological
injury motor status (complete vs. incomplete, 7 ± 2.8 vs.
4 ± 1.8, p = 0.04), but not in other QoL scales. After stratifying by mechanism of injury, participants in Fall and in
MVA groups showed a signiﬁcant negative correlation
between average pain intensity and rating of physical health
(Fall: ρ = −1.000, p < 0.0001, N = 5; MVA: ρ = −0.889, p
= 0.044, N = 5).
Pain type also did not show any difference in the QoL
scales with regard to SCI level, mechanisms of injury, or
neurological injury motor status. The Spearman correlations
among the years post-injury and the general QoL scale,
rating of physical health, and satisfaction with psychological health was not statistically signiﬁcant, but the results
suggested that there might be positive correlations. When
participants were stratiﬁed by the mechanism of injury, it
showed that years post-injury was positively and marginally
signiﬁcantly correlated to the rating of physical health in
MVA group (ρ = 0.775, p = 0.041, N = 7). There was no
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Discussion

Fig. 3 Pain interference: participants were asked to rate their pain
interference in response to the questions: a In general, how much has
pain interfered with your day-to-day activities in the last week? b In
general, how much has pain interfered with your ability to get a good
night’s sleep? c In general, how much has pain interfered with your
overall mood in the last week? The x axis in (c) applies to all and
shows the pain interference score, (0 is no interference and 10 is the
worst interference). The y axis shows the corresponding number of
participants who responded with that interference score. Data shown
are from Visit 1

correlation between years post injury and general QoL or
satisfaction with psychological health in participants with or
without pain, or by pain type.

Clinical and demographic data from participants in this
study is generally consistent with data from the NIH SCI
Model Systems database: the majority of participants were
male, had cervical level injuries and the most common AIS
grades were A and D (Table 1). The most common etiologies of injury here were Fall and Sports, the latter of which
is not as common nationally as motor vehicle accidents [3].
In this study, the majority of participants reported experiencing pain, including more than one pain problem, consistent with national and international data (Fig. 1) [3, 5,
18–21]. Pain intensity has been reported as moderate to
severe across studies and as expected, pain negatively
impacts overall QoL in persons with SCI (e.g., [1, 22, 23]).
To manage pain symptoms, many people with SCI are
prescribed multiple therapies, including gabapentin/pregabalin, and tricyclic antidepressants for neuropathic pain, and
physical therapy, exercise, and NSAIDS for nociceptive
pain [19, 21]. Concurrent pharmacologic treatments are
typical for persons with SCI and in this study more than two
thirds of participants received pharmacological treatment
for pain, with pregabalin or gabapentin the most common
medication taken, along with NSAIDS. This was also
recorded in a recent study in Italy using an Italian translation of the ISCIPBDS [24].
Unfortunately, despite taking medications for multiple
types of pain, pain symptoms persist after SCI, and here we
found that participants were almost evenly divided on
whether they reported nociceptive or neuropathic pain as
their worst pain problem (Table 3). Nociceptive pain was
the most common second and third worst pain problem. A
study of pain among individuals with SCI in Switzerland
using the International SCI Pain Basic Data Set yielded
similar results: 68.9% had some kind of pain in the past
week, with the most common pain type nociceptive (musculoskeletal), followed by neuropathic pain (below level),
41.6% [25]. A large study (N = 643) of individuals with
SCI in Ireland that used the International SCI Pain Basic
Data Set similarly found that 76% of respondents used
pharmacological treatment for pain, 71% had some kind of
pain, with nociceptive and neuropathic pain experienced by
32% and 37% of the respondents, respectively [26].
For the worst pain problem, pain intensity was over 7 on
a NRS, which was higher for neuropathic pain at both study
visits (Fig. 2). In Ireland, the average pain intensity was
6.3 ± 2.2 [26]. In the Swiss study, average pain intensity
over the past week was 6 ± 2 [25]. For the worst pain problem, pain location was most commonly reported here as
neck/shoulders, which is consistent with previous literature
from the SCI population [27, 28].
As found here, a meta analysis of 42 studies concluded
that often there is no correlation between injury

Spinal Cord Series and Cases (2019)5:32

completeness or level and pain [1]. A retrospective study
from a Swiss pain center that used the ISCIP classiﬁcation
of pain found that 58% of participants (N = 66) had nociceptive pain, 53% had at-level and 42% had below-level
neuropathic pain [29]. Here, 38% of persons had at-level
and 62% of persons had below-level neuropathic pain.
In a study of persons (N = 90) followed at 1, 6, and
12 months after SCI, 80% of participants had pain at all
time points, 59% had neuropathic and nociceptive pain at 1
year after SCI, and the percentage of individuals with
neuropathic pain increased over time [20]. In another study
of Siddall and colleagues that continued for ﬁve years after
SCI, 81% of participants reported pain, of which nociceptive (musculoskeletal) was the most common (59% of
participants), and 41% and 34% reporting at-level and
below-level neuropathic pain, respectively [18]. Half of
participants reported pain of any type within the ﬁrst three
months after SCI and the average time of any type of pain
onset was 1.6 years after SCI, with at-level neuropathic pain
onset a bit earlier, at 1.2 years after SCI [18]. While we did
not address onset of pain here, data from Siddall and colleagues showed that individuals with neuropathic pain
within the ﬁrst six months post SCI were likely to have
ongoing severe pain ﬁve years after injury [18].
In addition to pain, SCI often triggers psychosocial
changes that can negatively impact QoL [30, 31]. On the
ISCIPBDS, pain interference ranged from 0–10 on the
different subscales and was highest for most participants on
the question related to sleep interference (Fig. 3). Multiple
factors, including pain, other medical comorbidities, psychosocial support, community integration, and socioeconomic resources, have been shown to impact QoL after
SCI. Using the QoL Basic Data set, QoL scores were lower
for participants with SCI than AB persons (Fig. 4), consistent with a recent validity study [14]. A survey study of
individuals with SCI showed that the presence and intensity
of pain correlated with interference in general activity,
mood, mobility, interpersonal relationships, self-care, and
other facets of daily living [27]. Other studies demonstrated
that pain intensity correlated with pain interference also
showed that psychosocial factors such as coping mechanisms, such as catastrophizing contributed to greater pain
perception and pain interference [32, 33]. Therefore, as
there are many factors that can impact QoL scores, it is not
surprising that we did not observe a signiﬁcant correlation
between pain presence or intensity with QoL scores in this
relatively small number of participants.
Overall, these data reinforce the notion that despite being
treated for pain, most individuals with SCI are living with
multiple pain problems and that lower QoL needs to be
addressed in individuals with SCI. There are several
strengths of this study. To our knowledge, this is the ﬁrst
study to use the International SCI Pain Basic and the QoL
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Fig. 4 Quality of Life: At visit 1, participants were asked to rate their QoL
over the last 4 weeks on a scale of 0–10, where 0 is completely dissatisﬁed
and 10 is completely satisﬁed. Graphs indicate ratings of: a overall QoL, b
satisfaction with physical health, c satisfaction with psychological health,
emotions and mood. Data from participants with chronic SCI and AB
participants are shown in black and gray, respectively
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Data Sets prospectively in persons with chronic SCI. Data
were collected from the same participants at two study visits
held six months apart and the clinical/demographic characteristics were generally consistent with national US data.
There were several limitations to this study, including the
relatively small sample size and incomplete data collection
from all participants, including that a minority of participants (19%) did not complete the second study visit.
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